Applicant, as named in the Orange Book
Accord
Next listed expiry: Camcevi Etm on 1 Jan 2039. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Camcevi Etm leuprolide mesylate | 1 Jan 2039 |
| Camcevi Kit leuprolide mesylate | 1 Jan 2039 |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.